Dr. Mario A. Zetter Salmón

Summary:

Full academic degree:

M.D, Ph.D. in biomedical sciences

Nationality:

Mexican

I+D+i groups to which he belongs:

Topics of his interest:

About him:

Holds a M.D. Degree from the Autonomous University of Aguascalientes (2008-2015) and a Ph.D. in Biomedical Sciences (2016-2020) from UNAM. He carried out his doctoral studies in the Experimental Pathology Section, of the Department of Pathological Anatomy of the Salvador Zubirán National Institute of Medical Sciences and Nutrition, where he was awarded the José Antonio Martín Mora prize for presenting the best doctoral thesis of the institute. During this period, his studies focused on studying the neuroimmune-endocrine response in an experimental model of pulmonary tuberculosis.

Subsequently, he obtained a UNAM institutional scholarship to carry out a postdoctoral research stay in the Laboratory of Systems Neurosciences at the School of Medicine of the UNAM under the mentorship of the renowned neuroscientist Dr. Limei Zhang. During this period, he carried out research on the role of neuropeptides in different models of physiological stress and studies on neurohistology and fine neuroanatomy, as well as in work related to neuroimmunology, neuroinflammation, and during the COVID-19 epidemic he published works related to the pathophysiology of this disease that have received a good number of citations.

He has presented his research work at national and international conferences (Israel, Scotland) and was part of the steering committee (treasurer) of the International Society on Regulatory Peptides (IRPS) as well as in the co-organization of two congresses of this society (RegPep22, Acapulco Guerrero; RegPep23, Stirling, Scotland). He is also a member of the Society for Neurosciences.

His lines of research cover various fields of neuroimmunology and neuroendocrinology, at a morphological and physiological level, related to the organism’s adaptation to stress and how neuropeptides intervene in the physiological and allostatic networks in these processes; as well as the disruption of these when the body becomes ill. He has published 11 articles on these topics in high-impact international journals.

Projects:

Projects he has made:

Conferences:

Outreach speeches:

  • Zetter, M. (2022) 24th RegPep symposium: Vasopressin boosts PSD95 and GluA1 expression in limbic system, Stirling, Escocia.
  • Zetter, M. (2021) 23rd RegPep symposium: Microglial synaptic pruning and neuropeptides, Acapulco Guerrero, México.
  • Zetter, M. (July de 2020) 20th FENS (Federation of European Neuroscience Societies) virtual forum. Early life stress alters synaptic pruning in DG granule cells’ axon initial segment: does neuropeptide play a role on microglial abnormal activity?
  • Zetter, M. (October, 2019) III congreso de la sociedad mexicana de Neuroinmunoendocrinología. Poster presentation: “El papel de la vasopresina en la inmunopatología de la tuberculosis pulmonar experimental”, 6.1.8 “Innate immunity in health and Infectious Diseases” Institut.
  • Zetter, M. (2019) 13th World Congress of Neurohypophysial Hormones, Ein Gedi, Israel. Oral presentation (poster blitz) and poster: “Involvement of Vasopressin in the pathophysiology of tuberculosis”.
  • Zetter, M. (2018) 22nd International Symposium of Regulatory Peptides, Acapulco, México, 2018. Poster presentation: “Contribution of vasopressin to pulmonary tuberculosis immunopathology”,
  • Zetter, M. (May, 2018) XIII congress of the Latin-American society of Immunology. Oral presentation: “The contribution of vasopressin to pulmonary tuberculosis immunopathology”, neuroimmunoendocrinology workshop.
  • Zetter, M. (April, 2016) Theoretical and practical course on innate immunity (participant), Universidad Autónoma de Aguascalientes, Poster presentation. 1.9 “International meeting, New trends in Immunology”, Zacatecas, Mexico. Poster: “Papel inmunopatogénico del Factor Inhibidor de la Migración de los Macrófagos (MIF) en el desarrollo de la tuberculosis pulmonar progresiva experimental”.

Publications:

Indexed articles:

  • Hernández, O., Hernández, V., Zetter, M., Eiden, L., Zhang, L. (September 21th, 2022) Nucleus of the lateral olfactory tract: A hub linking the water homeostasis-associated supraoptic nucleus-arginine vasopressin circuit and neocortical regions to promote social behavior under osmotic challenge. J Neuroendocrino, e13202. DOI: 10.1111/jne.13202. Epub ahead of print. PMID: 36283814. 5.2
  • Wu, C., Zetter, M. (2022) Role of the hypothalamic paraventricular nucleus in anxiety disorders. Stress and Brain, Vol. 2(3), pp. 53-65. https://doi.org/10.26599/SAB.2022.9060019
  • Flores, E., Zetter, M., Hernández, R., Domínguez, E. (2022) Mathematical Model of the Immunopathological Progression of Tuberculosis. Front. Syst. 2, Vol. 912974. DOI: 10.3389/fsysb.2022.912974
  • Zhang, L., Padilla, T., Hernández, V., Zetter, M., Campos, E., Escobar, L., Millar, R., Eiden, L. (September, 2022) Vasopressin acts as a synapse organizer in limbic regions by boosting PSD95 and GluA1 expression. J Neuroendocrinol. Vol. 34(9):e13164. DOI: 10.1111/jne.13164. Epub, June 6th, 2022. PMID: 35666232.
  • Lara, J., Santana, R., Maldonado, P., Zetter, M., Becerril, E., Pérez, G., Pavón, L., Mata, D., Barrios, J., López, M., Marquina, B., Hernández, R. (December 13th, 2020) Experimental Pulmonary Tuberculosis in the Absence of Detectable Brain Infection Induces Neuroinflammation and Behavioural Abnormalities in Male BALB/c Mice. Int J Mol Sci.Vol. 21(24), pp. 9483. doi: 10.3390/ijms21249483. PMID: 33322180; PMCID: PMC7763936. 5.5
  • Hernández, V., Zetter, M., Guerra, E., Hernández, I., Karuzin, N., Hernández, O., Eiden, L., Zhang, L. (November, 2021) ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations. Exp Neurol. Vol. 345, pp. 113837. DOI: 10.1016/j.expneurol.2021.113837. Epub, August 13th, 2021. PMID: 34400158; PMCID: PMC8361001.
  • Zhang, L., Zetter, M., Guerra, E., Hernández, V., Mahata, S., Eiden, L. (February, 2021) ACE2 in the second act of COVID-19 syndrome: Peptide dysregulation and possible correction with oestrogen. J Neuroendocrinol. Vol. 33(2), e12935. DOI: 10.1111/jne.12935. Epub, January, 2021. PMID: 33462852; PMCID: PMC7995212.
  • Zetter, M., Hernández, V., Roque, A., Hernández, O., Gómora, M., Ruiz, S., Eiden, L., Zhang, L. (July, 2021) Microglial synaptic pruning on axon initial segment spines of dentate granule cells: Sexually dimorphic effects of early-life stress and consequences for adult fear response. J Neuroendocrinol. Vol. 33(7), e12969. DOI: 10.1111/jne.12969. Epub, April 22th, 2021. PMID: 33890333.
  • Zhang, L., Hernández, V., Zetter, M., Eiden, L. (April, 2020) VGLUT-VGAT expression delineates functionally specialised populations of vasopressin-containing neurones including a glutamatergic perforant path-projecting cell group to the hippocampus in rat and mouse brain. J Neuroendocrinol. Vol. 32(4), e12831. DOI: 10.1111/jne.12831. Epub, February 13th, 2020. PMID: 31944441
  • Zetter, M., Barrios, J., Mata, D., Marquina, B., Quintanar, A., Hernández, R. (2019) Involvement of Vasopressin in the Pathogenesis of Pulmonary Tuberculosis: A New Therapeutic Target? Front. Endocrinol. 10:351. DOI: 10.3389/fendo.2019.00351

Gallery:

✉: mario.zetter@lasalle.mx
☏: 55 5278 9500 Ext. 2825
Belongs to National System of Researchers (SNI) Level Candidate
💻: ResearchGate
💻: Google Scholar
💻: ORCID